– Bloomberg
Barclays Maintains Overweight on AerCap Holdings, Lowers Price Target to $58
Barclays analyst Mark Devries maintains AerCap Holdings (NYSE:AER) with a Overweight and lowers the price target from $72 to $58.
Related Posts
Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements
Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ:CELZ), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology,
Trump Media, CXApp, Micron Technology, Walgreens, Tesla: Why These 5 Stocks Are On Investors’ Radars Today
Monday's trading session saw a mixed performance in the U.S. stock market. The Dow Jones Industrial Average fell over 240 points, trading down 0.6% to 39,566.85
Vext Science Q1 Revenue Declines 15.6% YoY, What About Income?
Vext Science, Inc. (OTCQX: VEXTF) (CSE:VEXT) released its financial results for the period ended March 31, 2023, revealing revenue of $9.1 million a decrease of 15.6% compared to $10.8 million in Q1 2022.